PLUR
Pluri Inc. Common Stock
stockNASDAQ
pluristem therapeutics inc. (nasdaqcm: psti, tase: psti/pltr) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3d) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation. pluristem's placental expanded (plx) cells are placenta-derived, mesenchymal-like adherent stromal cells that are designed to be administered to patients without the need for tissue or genetic matching. these cells release soluble biomolecules, such as cytokines, chemokines and growth factors, which act in a paracrine or endocrine manner to facilitate healing of damaged tissues by stimulating the body's own regenerative mechanisms. the company's proprietary, 3d expansion technology can be used to grow plx cells in mass quantities with batch-to-batch consistency at pluristem's fda, ema and pmda-approved, state-of-the art manufacturing facility. pluristem's first product candi
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.94 | 2026-10-15 | +11.70% | 4.322 |
| 1M | 1.10 | 2026-09-22 | -4.54% | 1.348 |
| 3M | 1.85 | 2026-07-22 | -43.24% | 0.616 |
| 6M | 3.35 | 2026-04-22 | -68.66% | 0.890 |
| 1Y | 3.87 | 2025-10-22 | -72.85% | 0.567 |
| 2Y | 4.56 | 2024-10-22 | -76.97% | — |
| 5Y | 8.00 | 2022-07-27 | -86.87% | 0.038 |
Pluri Inc. Common Stock (NASDAQ:PLUR) stock price today is $1.05, and today's volume is 4,965. PLUR is up 0.000% today. The 30 day average volume is 16,889. PLUR market cap is $13.24M with 12.61M shares outstanding.